Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery

Recruiting now · Not applicable

Conditions studied: Tooth Extrusion, Wound Healing

In brief

Oral tissue healing is significantly affected by the high bacterial load and constant mechanical stress within the oral cavity. To control bacterial colonization and support healing, both topical and systemic treatments-such as antibiotics and anti-inflammatory agents-are commonly recommended. In addition to pharmacological therapies, mouthwashes containing peroxide, hyaluronic acid, chitosan, or chlorhexidine are often used to maintain low levels of pathogenic bacteria. However, current recommendations for mouthwash use are primarily based on their antibacterial properties in a healthy oral environment. Evidence supporting their role in promoting wound healing, particularly after oral surgery, remains limited. OROXID® mouthwash is a medical device formulated with active oxygen (peroxide compounds). It supports the prevention and relief of inflammation in gingival and paranasal tissues through mechanical action: the release of oxygen bubbles helps cleanse tissues by removing debris. OROXID® acts locally on the mucosal microenvironment by moistening, oxygenating, and clearing away particles and dead cells. Additionally, its slightly acidic pH (between 3 and 5) helps inhibit microbial growth. The investigators hypothesize that OROXID® may reduce post-operative side effects and complications following wisdom tooth extraction and contribute to faster wound healing.

Key facts

Study ID

NCT06987253

Run by

ENIKAM d.o.o.

People needed

60

Starts

2025-11-06

Expected to finish

2026-05-31

Last updated by the study team

2025-12-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Systemically healthy individuals aged 18 years or older.
• Indicated for surgical removal of an erupted or unerupted tooth and/or apicoectomy.
• Ability and willingness to comply with post-operative oral hygiene instructions.
• Signed informed consent form prior to participation in the study.

You may not qualify if…

• Receipt of periodontal treatment within the past 3 months.
• Use of mouthwashes or oral gels in the past month.
• Presence of active gingivitis around the tooth scheduled for extraction.
• Known allergy to any ingredients of the investigational products.
• Presence of inflammatory conditions in the oral cavity, such as lichen planus, bullous lesions, or active gingivitis.
• Immunocompromised individuals.
• Known allergy to penicillin or diclofenac.
• Pregnant or breastfeeding women.
• Smokers who consume more than 15 cigarettes per day.

Where it is running

• Klinika Križaj — Muljava, Municipality of Ivančna Gorica, Slovenia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.